Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
0.9204
+0.0157 (1.74%)
At close: Feb 6, 2026, 4:00 PM EST
0.9200
-0.0004 (-0.04%)
After-hours: Feb 6, 2026, 7:53 PM EST
BDMD Revenue
Baird Medical Investment Holdings had revenue of $7.96M in the half year ending June 30, 2025, a decrease of -31.06%. This brings the company's revenue in the last twelve months to $31.86M, down -3.60% year-over-year. In the year 2024, Baird Medical Investment Holdings had annual revenue of $37.04M with 17.74% growth.
Revenue (ttm)
$31.86M
Revenue Growth
-3.60%
P/S Ratio
0.75
Revenue / Employee
$222,797
Employees
143
Market Cap
33.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37.04M | 5.58M | 17.74% |
| Dec 31, 2023 | 31.46M | -3.63M | -10.35% |
| Dec 31, 2022 | 35.09M | 5.39M | 18.16% |
| Dec 31, 2021 | 29.70M | 11.58M | 63.92% |
| Dec 31, 2020 | 18.12M | 5.91M | 48.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nortech Systems | 116.67M |
| TELA Bio | 77.06M |
| Myomo | 41.64M |
| Cytosorbents | 36.98M |
| electroCore | 29.84M |
| Elutia | 21.75M |
| NeuroOne Medical Technologies | 12.10M |
| IceCure Medical | 2.98M |
BDMD News
- 10 days ago - Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass - PRNewsWire
- 12 days ago - Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital - PRNewsWire
- 18 days ago - Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference - PRNewsWire
- 4 weeks ago - Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam - PRNewsWire
- 7 weeks ago - Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&D - PRNewsWire
- 2 months ago - Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion - PRNewsWire
- 3 months ago - Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation - PRNewsWire
- 3 months ago - Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice - PRNewsWire